Russia Starting Human Trials for COVID-19 Vaccine Next Week

Human trials of Russia’s second potential coronavirus vaccine, developed by the Siberian Vector institute, will begin on July 27, Reuters reported citing Russian news agency TASS.

An early-stage human trial of a separate vaccine, developed by the Gamaleya Institute in Moscow, was completed this month, with scientists hailing the results and authorities planning to move to mass production in the autumn.